Medplus Health Services Limited (MEDPLUS) - Total Liabilities

Latest as of September 2025: Rs17.28 Billion INR ≈ $186.86 Million USD

Based on the latest financial reports, Medplus Health Services Limited (MEDPLUS) has total liabilities worth Rs17.28 Billion INR (≈ $186.86 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Medplus Health Services Limited (MEDPLUS) cash flow conversion to assess how effectively this company generates cash.

Medplus Health Services Limited - Total Liabilities Trend (2019–2025)

This chart illustrates how Medplus Health Services Limited's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Medplus Health Services Limited to evaluate the company's liquid asset resilience ratio.

Medplus Health Services Limited Competitors by Total Liabilities

The table below lists competitors of Medplus Health Services Limited ranked by their total liabilities.

Company Country Total Liabilities
Jiangsu Gian Technology Co Ltd
SHE:300709
China CN¥1.83 Billion
Phibro Animal Health Corporation
NASDAQ:PAHC
USA $1.07 Billion
Hunan Keli Motor Co Ltd
SHE:002892
China CN¥1.36 Billion
Sichuan Yimikang Environmental Tech Co Ltd
SHE:300249
China CN¥1.47 Billion
Sixt SE
XETRA:SIX3
Germany €5.56 Billion
Mader Group Ltd
AU:MAD
Australia AU$116.23 Million
Aevis Victoria SA
SW:AEVS
Switzerland CHF1.34 Billion
Taiflex Scientific Co Ltd
TW:8039
Taiwan NT$3.85 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Medplus Health Services Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Medplus Health Services Limited stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.90 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.94 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.48 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medplus Health Services Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medplus Health Services Limited (2019–2025)

The table below shows the annual total liabilities of Medplus Health Services Limited from 2019 to 2025.

Year Total Liabilities Change
2025-03-31 Rs16.20 Billion
≈ $175.22 Million
+13.50%
2024-03-31 Rs14.27 Billion
≈ $154.37 Million
+9.28%
2023-03-31 Rs13.06 Billion
≈ $141.26 Million
+11.00%
2022-03-31 Rs11.77 Billion
≈ $127.27 Million
+41.01%
2021-03-31 Rs8.35 Billion
≈ $90.25 Million
+1.83%
2020-03-31 Rs8.20 Billion
≈ $88.64 Million
+22.81%
2019-03-31 Rs6.67 Billion
≈ $72.17 Million
--

About Medplus Health Services Limited

NSE:MEDPLUS India Pharmaceutical Retailers
Market Cap
$1.13 Billion
Rs104.66 Billion INR
Market Cap Rank
#8584 Global
#408 in India
Share Price
Rs872.15
Change (1 day)
-0.96%
52-Week Range
Rs741.80 - Rs977.20
All Time High
Rs1290.00
About

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more